The global dermatome device market size is expected to reach USD 231.0 million by 2030, registering a CAGR of 5.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. There is a significant rise in the number of cosmetic procedures that are being carried out, globally. This is expected to boost the growth of the industry over the forecast period. In addition, factors, such as the rise in burn injuries and skin infections, are also driving industry growth. Skin grafting is an adequate treatment that is required in cosmetic surgery. A dermatome is used to carry out the skin grafting procedure in cosmetic surgery.
Thus, a rise in the number of cosmetic surgeries is leading to an increase in the sales of dermatome devices. For instance, according to the Aesthetic Society, in 2021, on average a plastic surgeon performed 320 surgical procedures, as compared to 220 in 2020 in the U.S. Dermatome device are also used in skin reconstitution in patients with trauma or grade 3 burns. The rising number of accidents and burn cases is therefore majorly contributing to a rise in product sales. For instance, according to an article posted by the American Burn Association in 2020, about 3,500 people are fatally injured in a fire or burn accident each year in the U.S.
The industry experienced a negative impact due to the COVID-19 pandemic majorly due to the postponement of elective procedures. However, the opening of the economies and the increasing focus of surgeons and the medical fraternity that was badly hit by the pandemic to recover from the losses faced led to a quick recovery of the industry in 2021. Furthermore, the industry is expected to flourish at a much faster pace owing to a rapid rise in the adoption of cosmetic surgeries.
Request a free sample copy or view the report summary: Dermatome Device Market Report
The powered dermatome device segment held the highest share in 2022 owing to the increased adoption rate across different applications
The chronic burn care segment accounted for the highest share in 2022 due to a rise in burn cases in both developed and developing countries
The plastic surgery segment is expected to register the fastest CAGR over the forecast period as a large number of people are opting for these procedures
The hospitals segment held the largest share in 2022 as a majority of the medical procedures that require dermatomes are covered under one setting for different applications
The Ambulatory Surgical Centers (ASCs) segment is expected to record the maximum growth over the forecast period owing to the rising popularity of plastic surgeries in these settings
North America was the dominant region in 2022 owing to the presence of well-established healthcare infrastructure
However, Asia Pacific is expected to have the fastest CAGR during the forecast period mainly due to the increasing number of burn cases and rising adoption of plastic surgeries
Grand View Research has segmented the dermatome device market based on product, application, end-use, and region:
Dermatome Device Product Outlook (Revenue, USD Million, 2018 - 2030)
Drum Dermatome Device
Knife Dermatome Device
Powered Dermatome Device
Pneumatic Dermatome Device
Battery Operated Dermatome Device
Electric Dermatome Device
Dermatome Device Application Outlook (Revenue, USD Million, 2018 - 2030)
Plastic Surgery
Reconstructive Surgery
General Surgery
Chronic Burn Care Treatments
Others
Dermatome Device End-Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Dermatology Clinics
Others
Dermatome Device Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Dermatome Device Market
Zimmer Biomet
Integra Lifesciences
B. Braun Melsungen AG
Aesculap, Inc.
Surtex Instruments Ltd.
DeSoutter Medical
Shaanxi Xingmao Industry Co., Ltd.
Aygun Surgical Instruments Co., Inc.
Humeca BV
Nouvag AG
Novo Surgical Inc.
"The quality of research they have done for us has been excellent..."